NCT04797637

Brief Summary

This paucity of evidence supporting or dissuading the use of postoperative abdominal support following cesarean section for the reduction of postoperative pain leaves important clinical questions unanswered. Additionally, there is an absence of long-term outcomes associated with the use of abdominal support devices. There remains a need for the development and implementation of nonpharmacologic methods for analgesia for women following cesarean sections, along with evidence-based recommendations regarding their use in postoperative patients. The ABBy (G-Squared Medical, Brentwood, TN) is an extended-wear panniculus retractor/tissue stabilizer that is intended for use postoperatively after abdominal procedure. It is placed directly onto patient skin, superior to a transverse incision, and is then used to elevate redundant tissues away from an incision or wound (https://www.gsquaredmedical.com/How-it-Works.html). The ABBy can be removed and replaced by patients and can be used for up to 10 days. This study aims to assess the effect of ABBy use on postoperative pain, pain medication requirement, and patient satisfaction, when used as a patient-positioning device in women following cesarean delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
278

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 9, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 15, 2021

Completed
17 days until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2022

Completed
6 months until next milestone

Results Posted

Study results publicly available

January 6, 2023

Completed
Last Updated

August 22, 2023

Status Verified

August 1, 2023

Enrollment Period

1.3 years

First QC Date

March 9, 2021

Results QC Date

December 13, 2022

Last Update Submit

August 21, 2023

Conditions

Keywords

cesareanc-sectionpostoperative pain

Outcome Measures

Primary Outcomes (1)

  • Total Morphine Milliequivalent (MME) Use Postoperatively After Cesarean Delivery

    Postoperative analgesia will be administered to all participants as per routine guidelines on postpartum.

    14 days postoperative

Secondary Outcomes (5)

  • Subjective Pain Scores During Use of Patient Positioning Device

    Baseline to 14 days postoperative

  • Patient Satisfaction During Use of Patient Positioning Device.

    Baseline to 14 days postoperative

  • Duration of Use of Patient Positioning Device.

    Baseline to 14 days postoperative

  • Number of Participants With Surgical Complications in Groups With and Without Patient Positioning Device

    Baseline to 14 days

  • Surgical Costs in Groups With and Without Patient Positioning Device

    Baseline to 14 days

Study Arms (2)

Treatment Group

EXPERIMENTAL

Patients randomized to the treatment group will have the ABBy device applied by study personnel at the time of randomization, followed by a continuation of usual postoperative care.

Device: ABBy® Adjustable Panniculus Retractor for Wound Care

Standard of Care

NO INTERVENTION

The control group will have postoperative care per usual care

Interventions

The ABBy (G-Squared Medical, Brentwood, TN) is an extended-wear panniculus retractor/tissue stabilizer that is intended for use postoperatively after abdominal procedure. It is placed directly onto patient skin, superior to a transverse incision, and is then used to elevate redundant tissues away from an incision or wound (https://www.gsquaredmedical.com/How-it-Works.html). The ABBy can be removed and replaced by patients and can be used for up to 10 days. This study aims to assess the effect of ABBy use on postoperative pain, pain medication requirement, and patient satisfaction, when used as a patient-positioning device in women following cesarean delivery.

Also known as: Abby device
Treatment Group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis is a obstetric study and only affects women.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Cesarean delivery
  • \<36 hours post-delivery

You may not qualify if:

  • Vertical skin incision
  • Inability to place device superior to incision
  • Presence of surgical drain
  • Opioid use disorder
  • Chronic opioid use (\> 14 consecutive days during pregnancy)
  • Allergy to device adhesive
  • Active COVID-19 infection
  • Patient unable to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

Location

Related Publications (10)

  • ACOG Committee Opinion No. 742: Postpartum Pain Management. Obstet Gynecol. 2018 Jul;132(1):e35-e43. doi: 10.1097/AOG.0000000000002683.

    PMID: 29781876BACKGROUND
  • Corso E, Hind D, Beever D, Fuller G, Wilson MJ, Wrench IJ, Chambers D. Enhanced recovery after elective caesarean: a rapid review of clinical protocols, and an umbrella review of systematic reviews. BMC Pregnancy Childbirth. 2017 Mar 20;17(1):91. doi: 10.1186/s12884-017-1265-0.

    PMID: 28320342BACKGROUND
  • Eisenach JC, Pan PH, Smiley R, Lavand'homme P, Landau R, Houle TT. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain. 2008 Nov 15;140(1):87-94. doi: 10.1016/j.pain.2008.07.011. Epub 2008 Sep 24.

    PMID: 18818022BACKGROUND
  • Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008.

    PMID: 26827847BACKGROUND
  • Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: Final Data for 2018. Natl Vital Stat Rep. 2019 Nov;68(13):1-47.

    PMID: 32501202BACKGROUND
  • Stoker KC. Use of Abdominal Binders for Postoperative Pain After Gastrointestinal Surgery: An Integrative Review. J Perianesth Nurs. 2019 Aug;34(4):829-833. doi: 10.1016/j.jopan.2018.10.010. Epub 2019 Feb 7.

    PMID: 30745077BACKGROUND
  • Ossola P, Mascioli F, Coletta D, Pizzato M, Bononi M. Evidence on postoperative abdominal binding: A systematic review with meta-analysis of randomized controlled trials. Surgeon. 2021 Aug;19(4):244-251. doi: 10.1016/j.surge.2020.07.003. Epub 2020 Aug 6.

    PMID: 32773235BACKGROUND
  • Gillier CM, Sparks JR, Kriner R, Anasti JN. A randomized controlled trial of abdominal binders for the management of postoperative pain and distress after cesarean delivery. Int J Gynaecol Obstet. 2016 May;133(2):188-91. doi: 10.1016/j.ijgo.2015.08.026. Epub 2016 Jan 14.

    PMID: 26892694BACKGROUND
  • Gustafson JL, Dong F, Duong J, Kuhlmann ZC. Elastic Abdominal Binders Reduce Cesarean Pain Postoperatively: A Randomized Controlled Pilot Trial. Kans J Med. 2018 May 18;11(2):1-19. eCollection 2018 May.

    PMID: 29796155BACKGROUND
  • Zuckerwise LC, Mulhall JC, Thompson JL, Jackson LA, McNeill-Simaan EO, Osmundson SS. Effect of panniculus elevation device on postoperative pain after cesarean delivery: a randomized controlled trial. Am J Obstet Gynecol MFM. 2023 May;5(5):100920. doi: 10.1016/j.ajogmf.2023.100920. Epub 2023 Mar 6.

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Results Point of Contact

Title
Lisa C. Zukerwise, MD
Organization
Vanderbilt University Medical Center

Study Officials

  • Lisa Zuckerwise, MD

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized in a 1:1 ratio using permutated blocks of 6. REDCap will be used for randomization, using an uploaded randomization sequence. A member of the study team will access REDCap to complete randomization.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Obstetrics and Gynecology

Study Record Dates

First Submitted

March 9, 2021

First Posted

March 15, 2021

Study Start

April 1, 2021

Primary Completion

July 20, 2022

Study Completion

July 20, 2022

Last Updated

August 22, 2023

Results First Posted

January 6, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations